Dayward Sleep FAQ: insomnia care, prescriptions, and coverage.

Those are general mental-health telehealth platforms. They are not sleep medicine clinics. Their clinicians are not board-certified in sleep medicine, and their model is built around medication management for anxiety and depression, with sleep treated as a downstream symptom.

Dayward is a sleep medicine clinic. Every clinician you see here is board-certified in sleep medicine. The assessment is pattern-matched to how your sleep breaks (onset, maintenance, early-morning, or non-restorative), and the treatment plan is built around that pattern, not around a general anxiety protocol.

You are not a CBT-I failure. CBT-I is the first-line treatment for chronic insomnia and the evidence behind it is real, and it is incomplete for complex cases. If you have completed a full protocol and the pattern persists, that is a signal that the case needs the pharmacological lane on top of the behavioral one, not that the behavioral work was wasted.

Our Guided Sleep Program is built for exactly this situation. Your clinician will read what you have already tried, including which CBT-I components you completed and where the response broke down, before your first consultation. The behavioral foundation stays in place; medication targets the mechanism that the behavioral work alone did not reach.

Yes. Before your first consultation, not during it. The pre-consultation review is the part of the model that distinguishes us from the four-minute appointment you have probably been through ten times.

We ask, in the intake, what you have tried, including doses, durations, what helped at first, what stopped helping, and what gave you side effects you could not tolerate. Your clinician reads this before they meet you. The first consultation starts where your history actually leaves off, not from zero.

For chronic insomnia, no. Sleep hygiene (consistent bedtime, dim lights at night, no screens late, no caffeine after noon) is real and useful at the foundation, but on its own it is not a treatment for an established chronic pattern. Patients who arrive at Dayward have usually been told to try sleep hygiene multiple times before anyone asked which of the four insomnia patterns they actually have.

Behavioral consistency is part of what CBT-I and our Sleep Reset program build on. It is not the whole answer for chronic insomnia, and treating it as the whole answer is part of why so many patients end up here.

The Sleep Pattern Assessment is a roughly two-minute structured intake that maps which of the four insomnia patterns your sleep is breaking in: onset, maintenance, early-morning awakening, or non-restorative. It also screens for sleep apnea risk indicators.

The output is a pattern profile that routes you into the treatment plan that fits, and that your clinician reads before your first consultation. It is the diagnostic layer most insomnia patients never get.

In most cases, yes. The first job of the clinical review is to understand what is already on board and how it is working, not to clear the slate and start over. If something in your current regimen is working partially, your clinician will build around it rather than against it.

If a change is recommended, for example, transitioning off a medication that is generating side effects or trading one problem for another, the clinician will explain the mechanism reason for the change and walk you through the transition. Nothing is changed without a conversation.

We do not treat apnea with hypnotics. That combination is contraindicated and harmful. We do screen for apnea as part of every Sleep Pattern Assessment, and if your responses suggest sleep-disordered breathing, we route you into our Apnea Pathway.

That pathway includes home sleep testing, an AHI result with a written clinical summary, and referral to in-network apnea management. If you have both apnea and insomnia, we coordinate the two tracks rather than treating them in isolation.

Honestly: it depends on the pattern and the lane. Behavioral work compounds over weeks. Pharmacological lanes have different onset profiles. Some medications begin to affect sleep within the first few nights, others require titration over weeks to find the right dose. Your clinician will explain the timeline that applies to your specific plan, with mechanism reasons.

What we will not do is promise a number. The patients who arrive here have usually been promised many numbers by many providers, and the promises are part of why the field has lost their trust.

At the low doses prescribed for sleep maintenance (typically 3 to 6 mg), doxepin acts as a selective histamine-1 receptor antagonist. It is not classified as a controlled substance and is not habit-forming in the same way benzodiazepines or Z-drugs can be.

That said, no medication is risk-free, and doxepin has its own side-effect profile your clinician will review with you. The point is that the dependence pattern people commonly worry about with sleep medications does not apply here.

This is a clinician-by-clinician decision based on the specific medication, the dose, your stage of lactation, and the rest of your clinical picture. Some sleep medications have safer lactation profiles than others, and your clinician will review your situation in detail before prescribing anything.

We will not give you a blanket yes or no on a content page. If you are breastfeeding and considering treatment, complete the Sleep Pattern Assessment and your clinician will discuss the specific options that are appropriate for your situation.

For most onset and maintenance insomnia, no. The Sleep Pattern Assessment plus your treatment history gives the clinician enough to evaluate and plan care.

For suspected sleep apnea, yes. The Apnea Pathway includes a home sleep test that returns an AHI result and a written clinical summary. The Sleep Pattern Assessment screens for apnea risk and routes you to testing if the indicators are present.

For commercial medications, we send prescriptions to your preferred local or mail-order pharmacy.

For treatment plans that include compounded preparations, we use a 503B-licensed compounding pharmacy partner in our network. 503B facilities are FDA-registered outsourcing facilities that operate under federal current Good Manufacturing Practice standards, a higher regulatory bar than retail compounding pharmacies.

Dayward operates outside of insurance for the assessment and the Guided Sleep Program. We do this deliberately. Insurance reimbursement structures are part of what produces the four-minute appointment: clinicians are pushed toward visit volume, which is incompatible with the pre-consultation review and pattern-matched care that the model requires.

Many patients use HSA or FSA funds for the program. We provide an itemized superbill on request that you can submit to your insurer for possible out-of-network reimbursement; coverage varies.

Our medical clinicians are licensed across most US states and we are continuing to add coverage. The current list of covered states is shown on the assessment and at checkout before any payment is taken.

If your state is not yet covered for doctor-led care, you can still use Sleep Reset, the behavioral program, and we will notify you when medical coverage becomes available in your state.

Dayward Sleep has two main care tiers. Sleep Reset, the behavioral program, is $49 per month. The Guided Sleep Program, the doctor-led plan, is $149 to $199 per month depending on the plan you choose. The Apnea Pathway is priced separately because referral and testing costs vary.

Both tiers are typically HSA and FSA eligible. For the full side-by-side comparison and a current pricing matrix, see /pricing.